Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Half-matched bone marrow transplants show high survival in young aplastic anemia patients

22

Oct 2026

Half-matched bone marrow transplants show high survival in young aplastic anemia patients

Researchers at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Johns Hopkins Children's Center report that bone marrow transplant using half-matched family donors achieved a 96% survival rate among children, adolescent, and young adult patients with severe aplastic anemia, a rare, life-threatening disorder in which the bone marrow fails to produce enough healthy blood cells.

Research shows how the brain merges faces and voices to read emotions

22

Oct 2026

Research shows how the brain merges faces and voices to read emotions

Communicating effectively with others involves recognizing emotions from faces and voices. How does the brain process and integrate emotional information from visuals and sounds that others display? New in JNeurosci, Olivier Collignon, from the Catholic University of Louvain, Stefania Mattioni, currently at Ghent University, and colleagues mapped responses in people's brains to faces and voices expressing different emotions.

Global vaccine equity rules could save millions in future pandemics

22

Oct 2026

Global vaccine equity rules could save millions in future pandemics

Beginning the global COVID-19 vaccine roll-out 100 days after the virus was sequenced could have saved more than 8 million lives by the end of 2021, most of them in lower-middle-income countries, according to modelling evidence brought together in a new Policy Brief from the United Nations University Institute for Water, Environment and Health (UNU-INWEH).

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.